The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Jason Brown
Honoraria - Ipsen; Johnson & Johnson/Janssen
Consulting or Advisory Role - AstraZeneca; EMD Serono; Johnson & Johnson/Janssen; Pfizer
Speakers' Bureau - Merck
Research Funding - Bicycle Therapeutics (Inst); Indaptus Therapeutics; Merck (Inst); Novita Pharmaceuticals (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen
 
Andrea Apolo
No Relationships to Disclose
 
Deepak Kilari
Honoraria - Exelixis
Consulting or Advisory Role - Eisai; Exelixis; Janssen Oncology; Pfizer
Speakers' Bureau - Astellas Pharma; AVEO; Eisai; Exelixis; Janssen
Research Funding - Astellas Pharma (Inst); Exelixis (Inst); Genentech (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AVEO; Exelixis; Janssen
 
Elias Chandran
No Relationships to Disclose
 
Jianbin Zhu
No Relationships to Disclose
 
Pedro Barata
Stock and Other Ownership Interests - Luminate Medical
Honoraria - Medscape; UroToday
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; AVEO; Bayer; BMS; Caris Life Sciences; Dendreon (Inst); Eisai; EMD Serono; Exelixis; Ipson; Merck; Novartis; Pfizer
Speakers' Bureau - Astellas Pharma; AstraZeneca
Research Funding - AVEO (Inst); Blue Earth Diagnostics (Inst); Exelixis; Merck (Inst); Pfizer (Inst)
 
Thomas Giever
No Relationships to Disclose
 
Felipe Valerio
No Relationships to Disclose
 
Mary Alfieri
No Relationships to Disclose
 
Rajesh Sehgal
No Relationships to Disclose
 
Carlos Alemany
Stock and Other Ownership Interests - Novo Nordisk; Pfizer
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Olema Pharmaceuticals (Inst); Pfizer (Inst); Sanofi (Inst); Seagen (Inst)
 
Guru Sonpavde
Employment - Exact Sciences (I); Myriad Genetics (I)
Honoraria - Ideology Health; Onviv; PeerView; PrecisCa; UpToDate
Consulting or Advisory Role - Aktis Oncology; Astellas Pharma; Bicycle Therapeutics; Biosite; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Ellipses Pharma; EMD Serono; Exelixis; G1 Therapeutics; Gilead Sciences; GlaxoSmithKline; Janssen; Loxo/Lilly; Loxo/Lilly; Merck; Pfizer; Scholar Rock; Seagen; Syapse; Vial
Speakers' Bureau - Astellas Pharma; AstraZeneca; AVEO; Bayer; Exelixis; Gilead Sciences; Janssen Oncology; Merck; Natera; Pfizer; Research to Practice; Seagen
Research Funding - Bayer (Inst); Blue Earth Diagnostics (Inst); EMD Serono (Inst); Exelixis (Inst); Jazz Pharmaceuticals (Inst); Sumitomo Pharma Oncology (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
Other Relationship - Bristol-Myers Squibb; Elsevier; G1 Therapeutics; Merck; Mereo BioPharma; QED Therapeutics